New insider activity at NKGen Biotech ( (NKGN) ) has taken place on May 8, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CEO Paul Y. Song has made a significant investment in NKGen Biotech by purchasing 20,849,725 shares of the company’s stock, valued at $2,501,967. This move demonstrates confidence in the company’s future prospects.
More about NKGen Biotech
YTD Price Performance: -80.87%
Average Trading Volume: 3,883,959
Technical Sentiment Signal: Sell
Current Market Cap: $5.95M